Non-Tuberculous Mycobacteria Interference with BCG-Current Controversies and Future Directions
1
Department of Microbiology, Immunology and Pathology, Mycobacteria Research Laboratory, Colorado State University, 1682 Campus Delivery, 200 West Lake Street, Fort Collins, CO 80523, USA
2
Department of Medicine, Rocky Mountain Regional Veterans Affairs Medical Center, Denver, CO 80523, USA
3
Division of Pulmonary Sciences and Critical Care Medicine, Departments of Medicine and Academic Affairs, National Jewish Health, University of Colorado Anschutz Medical Campus, Denver, CO 80523, USA
*
Author to whom correspondence should be addressed.
Vaccines 2020, 8(4), 688; https://doi.org/10.3390/vaccines8040688
Received: 27 September 2020 / Revised: 4 November 2020 / Accepted: 12 November 2020 / Published: 16 November 2020
(This article belongs to the Special Issue Development of Vaccines against Tuberculosis: One Health Approach)
The global tuberculosis (TB) epidemic caused by the bacterial pathogen Mycobacterium tuberculosis (M.tb) continues unabated. The Mycobacterium bovis bacillus Calmette–Guérin (BCG) vaccination is widely utilized worldwide to protect against infection with M.tb. BCG vaccine protection against TB has had widely varying results for reasons that are not well understood. BCG vaccine interference by non-tuberculosis (NTM) mycobacterial species has been implicated as the potential cause of reduced BCG vaccine efficacy against M.tb. Ongoing efforts to develop new vaccines for TB requires a thorough understanding of the effect of NTM exposure on BCG vaccine efficacy, which may ultimately be a critical determinant of success. We reviewed the conflicting reports on whether NTM interferes with the BCG vaccine, potential explanations to help resolve the controversy, and strategies for developing better animal models. Further studies are needed to longitudinally track the effects of NTM exposure on BCG vaccine-induced host-protective anti-TB immunity.
View Full-Text
▼
Show Figures
Figure 1
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited
MDPI and ACS Style
Verma, D.; Chan, E.D.; Ordway, D.J. Non-Tuberculous Mycobacteria Interference with BCG-Current Controversies and Future Directions. Vaccines 2020, 8, 688. https://doi.org/10.3390/vaccines8040688
AMA Style
Verma D, Chan ED, Ordway DJ. Non-Tuberculous Mycobacteria Interference with BCG-Current Controversies and Future Directions. Vaccines. 2020; 8(4):688. https://doi.org/10.3390/vaccines8040688
Chicago/Turabian StyleVerma, Deepshikha; Chan, Edward D.; Ordway, Diane J. 2020. "Non-Tuberculous Mycobacteria Interference with BCG-Current Controversies and Future Directions" Vaccines 8, no. 4: 688. https://doi.org/10.3390/vaccines8040688
Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.
Search more from Scilit
